| |
Latest 10 SEC filings (by transaction date) for ARQT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 11/24 | Apr 11/24 | Topper David Joseph | Direct Ownership | Stock Option (right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Apr 11/24 | Apr 10/24 | Topper David Joseph | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 310,000 | |
Apr 11/24 | Apr 10/24 | Topper David Joseph | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 110,000 | |
Mar 6/24 | Mar 4/24 | Matsuda Masaru | Direct Ownership | Common Stock | S - Open market or private sale | -3,760 | $11.12 |
Mar 6/24 | Mar 4/24 | Burnett Patrick | Direct Ownership | Common Stock | S - Open market or private sale | -4,782 | $11.12 |
Mar 6/24 | Mar 4/24 | Watanabe Todd Franklin | Direct Ownership | Common Stock | S - Open market or private sale | -14,903 | $11.12 |
Mar 6/24 | Mar 4/24 | Moore Matthew Richard | Direct Ownership | Common Stock | S - Open market or private sale | -3,468 | $11.12 |
Mar 6/24 | Mar 4/24 | Heron Patrick J | Indirect Ownership | Common Stock | P - Open market or private purchase | 21,052 | $9.50 |
Mar 1/24 | Feb 28/24 | Watanabe Todd Franklin | Direct Ownership | Common Stock | S - Open market or private sale | -2,465 | $10.60 |
Feb 15/24 | Feb 13/24 | Moore Matthew Richard | Direct Ownership | Stock Option (Right to Buy) | D - Disposition to issuer under Rule 16b-3(e) | -39,500 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ARQT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 11/24 | Apr 10/24 | Topper David Joseph | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 310,000 | |
Apr 11/24 | Apr 10/24 | Topper David Joseph | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 110,000 | |
Apr 11/24 | Apr 11/24 | Topper David Joseph | Direct Ownership | Stock Option (right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Mar 6/24 | Mar 4/24 | Matsuda Masaru | Direct Ownership | Common Stock | S - Open market or private sale | -3,760 | $11.12 |
Mar 6/24 | Mar 4/24 | Burnett Patrick | Direct Ownership | Common Stock | S - Open market or private sale | -4,782 | $11.12 |
Mar 6/24 | Mar 4/24 | Watanabe Todd Franklin | Direct Ownership | Common Stock | S - Open market or private sale | -14,903 | $11.12 |
Mar 6/24 | Mar 4/24 | Moore Matthew Richard | Direct Ownership | Common Stock | S - Open market or private sale | -3,468 | $11.12 |
Mar 6/24 | Mar 4/24 | Heron Patrick J | Indirect Ownership | Common Stock | P - Open market or private purchase | 21,052 | $9.50 |
Mar 1/24 | Feb 28/24 | Watanabe Todd Franklin | Direct Ownership | Common Stock | S - Open market or private sale | -2,465 | $10.60 |
Feb 15/24 | Feb 13/24 | Moore Matthew Richard | Direct Ownership | Stock Option (Right to Buy) | D - Disposition to issuer under Rule 16b-3(e) | -39,500 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |